TRPV1 antagonists may exacerbate sepsis in aged mice: Should we be nervous?

Cell Cycle

Volumn 11, Issue 4, 2012, Pages 647-

  Quezado, Zenaide M ^a   Szallasi, Arpad ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b MONMOUTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; VANILLOID RECEPTOR 1 ANTAGONIST;

BACTERIAL CLEARANCE; DISEASE EXACERBATION; GENE DELETION; MOUSE; NEUROTRANSMISSION; NONHUMAN; NOTE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

MUS;

AGING; ANIMALS; FEMALE; INFLAMMATION MEDIATORS; MALE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRPV CATION CHANNELS;

EID: 84857498688     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.4.19168     Document Type: Note

References (9)

1. Moran MM, et al. Nat Rev Drug Discov 2011; 10:601-20; PMID:21804597; http://dx.doi.org/10.1038/nrd3456.
2. Wanner SP, et al. Cell Cycle 2012; 11: In press; PMID:22214765.
3. Hotchkiss RS, et al. N Engl J Med 2003; 348:138-50; PMID:12519925; http://dx.doi.org/10.1056/ NEJMra021333.
4. Martin GS, et al. N Engl J Med 2003; 348:1546-54; PMID:12700374; http://dx.doi.org/10.1056/NEJMoa022139.
5. Rosas-Ballina M, et al. Neuron 2009; 64:28-32; PMID:19840545; http://dx.doi.org/10.1016/j.neuron.2009.09.039.
6. Karai L, et al. J Clin Invest 2004; 113:1344-52; PMID:15124026.
7. Clark N, et al. FASEB J 2007; 21:3747-55; PMID:17601984; http://dx.doi.org/10.1096/fj.06-7460com.
8. Guptill V, et al. Anesthesiology 2011; 114:1190-9; PMID:21383614; http://dx.doi.org/10.1097/ ALN.0b013e318212515b.
9. Ang SF, et al. Crit Care Med 2010; 38:619-28; PMID:19851090; http://dx.doi.org/10.1097/CCM.0b013e3181c0df00.